The biopharmaceutical company has attained an elite worldwide license to several patents from the nonprofit Research Development Foundation (RDF), and the company develops gene therapy treatments for congestive heart failure and other chronic diseases. Along with group of patents, Renova Therapeutics’ has expanded its portfolio in the cardiovascular and metabolic disease space, thus imparting future road for its paracrine gene therapy product pipeline [more]
top of page
Search
Recent Posts
See AllGeneral Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
bottom of page
Comments